P. Halloran, K. Gallicano, and K. Wonigeit, Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel, Ther Drug Monit, vol.17, pp.642-54, 1995.

A. Rousseau, Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients, Clin Pharmacokinet, vol.45, pp.905-927, 2006.

Y. Meur, P. Westeel, P. Marquet, A. Francois, M. Hellot et al., A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits, Nephrol Dial Transplant, vol.25, pp.3096-106, 2010.

P. Jacobson, J. Ng, K. Green, J. Rogosheske, and R. Brundage, Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation, Biology of Blood and Marrow Transplantation, vol.9, issue.5, pp.304-315, 2003.
DOI : 10.1016/S1083-8791(03)00076-4

F. Saint-marcoux, Current Practice of Therapeutic Drug Monitoring, pp.103-123
DOI : 10.1016/B978-0-12-385467-4.00005-1

N. Picard, N. Djebli, F. Sauvage, and P. Marquet, Metabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5, Drug Metabolism and Disposition, vol.35, issue.3, pp.350-355, 2007.
DOI : 10.1124/dmd.106.012161

A. Boekmann, . Lbsheiner, and S. Beal, NONMEM User's Guide -Part V: Introductory Guide, 1994.

P. Marquet, Application of a gamma model of absorption to oral cyclosporin, Clin Pharmacokinet, vol.40, pp.375-82, 2001.

L. Guellec, C. Marquet, and P. , A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil, Clin Pharmacokinet, vol.44, pp.837-884, 2005.

J. Proost and D. Eleveld, Performance of an Iterative Two-Stage Bayesian Technique for Population Pharmacokinetic Analysis of Rich Data Sets, Pharmaceutical Research, vol.22, issue.12, pp.2748-59, 2006.
DOI : 10.1007/s11095-006-9116-0

J. Steimer, A. Mallet, J. Golmard, and J. Boisvieux, Alternative Approaches to Estimation of Population Pharmacokinetic Parameters: Comparison with the Nonlinear Mixed-Effect Model, Drug Metabolism Reviews, vol.82, issue.1-2, pp.265-92, 1984.
DOI : 10.1007/BF01061210

M. Neely, M. Van-guilder, W. Yamada, A. Schumitzky, R. Jelliffe et al., Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R, Therapeutic Drug Monitoring, vol.34, issue.4, pp.467-76, 2002.
DOI : 10.1097/FTD.0b013e31825c4ba6

A. Hooker, C. Staatz, and M. Karlsson, Conditional Weighted Residuals (CWRES): A Model Diagnostic for the FOCE Method, Pharmaceutical Research, vol.26, issue.12, pp.2187-97, 2007.
DOI : 10.1007/s11095-007-9361-x

S. Retout, F. Mentre, and R. Bruno, Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics, Statistics in Medicine, vol.26, issue.6, pp.2623-2662, 2002.
DOI : 10.1002/sim.1041

L. Sheiner and S. Beal, Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data, Journal of Pharmacokinetics and Biopharmaceutics, vol.8, issue.5
DOI : 10.1007/BF01061030

K. Barraclough, N. Isbel, and C. Staatz, Evaluation of the Mycophenolic Acid Exposure Estimation Methods Used in the APOMYGERE, FDCC, and Opticept Trials, Transplantation, vol.90, issue.1, pp.44-51, 2010.
DOI : 10.1097/TP.0b013e3181e06584

H. Zhou, Y. Gao, X. Cheng, and Z. Li, Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients, European Journal of Drug Metabolism and Pharmacokinetics, vol.26, issue.6
DOI : 10.1007/s13318-012-0087-8

Y. Zhou, X. Sheng, J. Xu, S. Bi, W. Lu et al., Population pharmacokinetic study of Cyclosporine in the hematopoietic stem cell transplant recipients, Int. Journal of Clinical Pharmacology and Therapeutics, vol.51, issue.07, pp.568-75, 2013.
DOI : 10.5414/CP201815